Presence of human papillomavirus DNA in voriconazole‐associated cutaneous squamous cell carcinoma. (14th February 2020)

• Record Type: Journal Article
• Authors: Nguyen, Cuong V.; He, Qin; Rady, Peter L.; Tyring, Stephen K.; Miller, Daniel D.; Rubin, Nathan; Kovarik, Carrie L.
• Is Part Of: International journal of dermatology. Volume 59:Number 5(2020)
• Page Start: 595
• Page End: 598
• Publication Date: 2020-02-14
• Subjects: Dermatology -- Periodicals; 616.5
• DOI: 10.1111/ijd.14820
• Languages: English
• ISSNs: 0011-9059

Abstract

Abstract: Background: Voriconazole and genus beta human papillomavirus (HPV) are independently associated with the development of photo‐exposed cutaneous squamous cell carcinoma (SCC) but have not been evaluated concurrently. The objective of this study is to determine the prevalence and type of detectable HPV DNA in voriconazole‐associated SCC. Methods: SCCs from immunosuppressed patients, in those with and without voriconazole exposure, were evaluated by PCR analysis for HPV DNA and compared to SCC from non‐immunosuppressed patients. An additional expanded PCR analysis of all SCC that developed in the voriconazole group was also performed. Results: HPV DNA was detected by PCR in all groups regardless of the immunosuppression status (80.5%) with beta HPV most prevalent (64.3–78.6%). However, immunosuppressed patients were significantly more likely to be infected by beta HPV types 5, 8, 14, 20, and 21 ( P ‐value 0.014), and represented the majority of beta HPV types found in the voriconazole group. Conclusions: In this retrospective study, beta HPV 5, 8, 14, 20, and 21 were commonly detected in voriconazole‐associated SCC. The results indicate a possible role of beta HPV in the pathogenesis of cutaneous SCC in photo‐exposed areas. Further studies are needed to establish the role of HPV and voriconazole in the pathogenesis of the lesion.